Study Summary
This trial will compare the effectiveness of cefixime to benzathine penicillin G in treating syphilis.
Eligible Conditions
- Syphilis
- HIV/AIDS
Treatment Effectiveness
Effectiveness Progress
This is further along than 85% of similar trials
Study Objectives
1 Primary Β· 0 Secondary Β· Reporting Duration: 6 months
6 months
Response to treatment
Trial Safety
Safety Progress
This is further along than 85% of similar trials
Trial Design
2 Treatment Groups
Benzathine Penicillin G
1 of 2
Cefixime
1 of 2
Active Control
Experimental Treatment
400 Total Participants Β· 2 Treatment Groups
Primary Treatment: Cefixime 400mg Β· No Placebo Group Β· Phase 3
Cefixime
Drug
Experimental Group Β· 1 Intervention: Cefixime 400mg Β· Intervention Types: DrugBenzathine Penicillin G
Drug
ActiveComparator Group Β· 1 Intervention: benzathine penicillin Β· Intervention Types: DrugTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Who is running the clinical trial?
AIDS Healthcare FoundationOTHER
12 Previous Clinical Trials
17,308 Total Patients Enrolled
1 Trials studying Syphilis
58 Patients Enrolled for Syphilis
University of Southern CaliforniaLead Sponsor
828 Previous Clinical Trials
1,429,604 Total Patients Enrolled
1 Trials studying Syphilis
60 Patients Enrolled for Syphilis
Universidad Peruana Cayetano HerediaOTHER
71 Previous Clinical Trials
61,044 Total Patients Enrolled
1 Trials studying Syphilis
60 Patients Enrolled for Syphilis
Eligibility Criteria
Age 18+ Β· All Participants Β· 4 Total Inclusion Criteria
Mark βYesβ if the following statements are true for you:were excluded from study enrollment
Individuals who had been diagnosed with syphilis within the past 3 weeks were not allowed to join the study.
The patient is able to provide informed consent if he or she is able to understand the information provided and the implications of the decision.
is allowed
People with HIV must take medication to control the virus and have a low viral load (less than 200 copies per milliliter) or a CD4 cell count of at least 350 cells per millimeter according to their most recent lab results in order to participate in this study.
You must be 18 years of age or older to gamble in the state of Nevada
Who else is applying?
What state do they live in?
| Nevada | 50.0% |
| California | 50.0% |
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 50.0% |
| Did not meet criteria | 50.0% |
What site did they apply to?
| University of Southern California | 100.0% |
How many prior treatments have patients received?
| 0 | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments